Rape Prevention and Education

The purpose of this NOFO is to build on the previous RPE NOFO, CDC-RFA-CE19-1902, by continuing to enhance the capacity of state and territorial health departments (hereafter referred to as SHDs) to facilitate and monitor the implementation of sexual violence (SV) prevention programs, practices, and policies. This five-year funding opportunity requires that recipients build infrastructure for SV prevention; develop/enhance a state/territory action plan; implement community- and societal-level SV prevention strategies that promote health equity; and utilize data to inform action. Completing these...

The Notice of Funding Opportunity (NOFO) is funded under the Violence Against Women Act (VAWA) and Section 393A(a) of the PHS Act (42 USC § 280b-1b(a) and Section 392(a)(1) of the PHS Act (42 USC § 280b-1(a)(1)) legislative authority. Eligible entities are based on the VAWA legislation. The legislative authority requires CDC to fund the Rape Prevention and Education Program (RPE) and allocate funds in each fiscal year for:Each of the States, the District of Columbia, Puerto Rico, and the U.S. Territories.State health departments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the US Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau).A Bona Fide Agent is an agency/organization identified by the state as eligible to apply under the state eligibility in lieu of a state application. This should be stated in the project abstract. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. 

Phillip D. Willams Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Violence Prevention 4770 Buford Highway NE, Building 106 MS- 106-10 Atlanta, GA 30341 Email: dpz4@cdc.gov